Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Marksans Pharma secures US FDA approval for multiple strengths of Pregabalin capsules in key neuropathic pain segment Marksans Pharma wins US FDA approval for multi-strength Pregabalin capsules, targeting a USD 263M neuropathic pain market in the United States. bySrinathJuly 21, 2022